The Cancer Letter

Inside information on cancer research and drug development

In Brief

MD Anderson’s Lee Named Medical Director of Texas Center for Proton Therapy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

ANDREW LEE was named medical director of the Texas Center for Proton Therapy, a collaboration of Texas Oncology, Baylor Health, McKesson Specialty Health, and The US Oncology Network, effective Feb. 1.

Lee was a professor in the Department of Radiation Oncology at MD Anderson Cancer Center, working there for over 13 years. He was medical director of MD Anderson’s Proton Therapy Center, and served as director of advanced technologies. He was recognized as a recipient of The University Cancer Foundation Faculty Achievement Award in Patient Care.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more
By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin
Table of Contents

Login

Looking for IP Login?